Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma. Am J Hematol 2021 Sep 01;96(9):E341-E344
Date
05/30/2021Pubmed ID
34050985DOI
10.1002/ajh.26255Scopus ID
2-s2.0-85108858009 (requires institutional sign-in at Scopus site) 4 CitationsAuthor List
Mohan M, Szabo A, Yarlagadda N, Gundarlapalli S, Thanendrarajan S, Kendrick S, Schinke C, Alapat D, Sawyer J, Tian E, Tricot G, van Rhee F, Zangari MAuthor
Aniko Szabo PhD Professor in the Institute for Health and Equity department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedBone Marrow
Female
Humans
Male
Middle Aged
Multiple Myeloma
Neoplasm, Residual
Prognosis
Survival Analysis
